LIST DO REDAKCJI
Cancer risk in relation to exposure to trace elements
 
Więcej
Ukryj
1
Laboratory for Environmental Health Research, Institute for Biomedical Research, Academy of Medicine, Lithuanian University of Health Sciences
AUTOR DO KORESPONDENCJI
Loreta Strumylaite
Institute for Biomedical Research Medical Academy Lithuanian University of Health Sciences Eiveniu 4 LT-50009 Kaunas Lithuania
 
Med Srod. 2011;14(1):7–12
 
SŁOWA KLUCZOWE
STRESZCZENIE ARTYKUŁU
W wielu częściach świata nowotwory są głównym zagadnieniem zdrowia publicznego. Powstawanie nowotworu jest zależne od wielu przyczyn , niektóre z nich są znane, jednak przyczyny innych nie są dotąd wyjaśnione. Istotne zróżnicowanie geograficzne odnośnie śmiertelności nowotworów narządowych w różnych regionach świata może być związane z czynnikami środowiskowymi i ze śladowymi metalami jak arsen, chrom i kadm. Niniejszy przegląd przedstawia aktualne badania na ten temat.

Cancer is a major public health concern in many parts of the world. The genesis of cancer is multi-causal with ome well known causal factors for some sites of cancer. However, some cancer causes are not clear up to nowadays. There are substantial geographic variations in mortality of some sites of cancer in different regions of the world that could be in relation with some environmental factors and trace elements such as arsenic, chromium and cadmium. The review summarizes the recent studies on that matter.
 
REFERENCJE (64)
1.
Parkin D.M., Bray F., Ferlay J., et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108.
 
2.
World Health Organization (WHO). Trace elements in human nutrition and health. World Health Organization,m Geneva 1996.
 
3.
Navarro Silvera S.A., Rohan T.E. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer CausesControl 2007; 18: 7–27.
 
4.
Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for arsenic. US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta, GA, 2003: Report No.: 7440-38-2.
 
5.
Rasmussen L., Andersen K.J.: Arsenic in drinking water (in:) World Health Organization, UNICEF (ed.): Environmental health and human exposure assessment. IWA, London, 2003:67–168.
 
6.
Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for cadmium. United States Department of Health and Human Services Agency for Toxic Substancesand Disease Registry, Atlanta, GA, 1999: Report No.: 7440–43-9.
 
7.
World Health Organization (WHO). Regional Office for Europe. Air quality guidelines, Second Ed. World Health Organization, Copenhagen, Denmark 2000.
 
8.
Lamm S.H., Engel A., Kruse M.B., et al: Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 2004; 46:.298–306.
 
9.
World Health Organization (WHO). Regional Office for Europe Air quality guidelines. Europian series No. 23. Copenhagen, 1987. 221–230.
 
10.
Polizzotto M.L., Kocar B.D., Benner S.G., et al.: Near-surface wetland sediments as a source of arsenic release to ground water in Asia. Nature 2008; 454: 505–508.
 
11.
Winkel L., Berg M., Amini M., et al.: Predicting groundwater arsenic contamination in Southeast Asia from surface parameters, Nat Geosci 2008; 1: 536–542.
 
12.
Yost L.J., Tao S.H., Egan S.K., et al.: Estimation of dietary intake of inorganic arsenic in US children. Hum Ecol Risk Assess 2004; 10: 473–483.
 
13.
Brima E.I., Haris P.I., Jenkins R.O., et al.: Understanding arsenic metabolism through a comparative study of arsenic level in the urine, hair and fingernails of healthy volunteer from three unexposed ethnic group in the United Kingdom. Toxicol Appl Pharmacol 2006; 216 : 112–130.
 
14.
Hata A., Endo Y., Nakajima Y., et al.: HPLCICP-MS speciation analysis of arsenic in urine of Japanese subjects without occupational exposure. J Occup Health 2007; 49: 217–223.
 
15.
Boffetta P., Nyberg F. Contribution of environmental factors to cancer risk. Br Med Bull 2003; 68:71-94.
 
16.
El-Masri H.A., Kenyon E.M.: Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and dimethylated metabolites. J Pharmacokinet Pharmacodyn 2008; 35: 31–68.
 
17.
Hughes M.F.: Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect 2006; 114: 1790–1796.
 
18.
Hsueh Y.M., Hsu M.K, Chiou H.Y., et al.: Urinary arsenic speciation in subjects with or without restriction from seafood dietary intake. Toxicol Lett 2002; 133: 83–91.
 
19.
Clewell H.J., Thomas R.S., Gentry P.R., et al.: Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report. Toxicol Appl Pharmacol 2007; 222: 288–398.
 
20.
Hsueh Y.M., Cheng G.S., Wu M.M., et al.: Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 1995; 71: 109-114.
 
21.
Bates M.N., Rey O.A., Biggs M.L., et al.: Case-control ctudy of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 2004;159:.381–389.
 
22.
Celik I., Gallicchio L., Boydet K. et al.: Arsenic in drinking water and lung cancer: A systematic review. Environ Res 2008; 108: 48–55.
 
23.
Chen Ch.L., YiChiou H., IHsu L., et al.: Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environ Res 2010; 110: 455–462.
 
24.
Heck J.E., Andrew A.S., Onega T., et al.: Lung Cancer in a U.S. Population with Low to Moderate Arsenic Exposure. Environ Health Perspect 2009; 117(11): 1718-1723.
 
25.
Chen B.C., Wei-Chun Choub, Wei-Yu Chenb, Chung-Min Liao. Assessing the cancer risk associated with arsenic-contaminated seafood. J Hazardous Materials 2010; 181: 161–169.
 
26.
Cantor K.P., Lubin J.H.: Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol Appl Pharmacol 2007; .22: 252–257.
 
27.
Krebs R.E.: The history and use of our Earth’s chemical elements: A Reference Guide. Second Ed. Greenwood Publishing Group, Santa Barbara, CA 2006: 96.
 
28.
Independent Environmental Technical Evaluation Group (IETEG) (in:) Guertin, J., Jacobs, J.A., Avakian, C.P. (ed.), Chromium (VI) Handbook. CRC Press, Boca Raton 2005.
 
29.
Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for chromium. Public health service, U.S. department of health and human services, Atlanta, GA 2000.
 
30.
Stavrides J.C.: Lung carcinogenesis. Pivotal role of metals in tobacco smoke. Free Radic Biol Med 2006; 41: 1017–1030.
 
31.
International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 49: Chromium, Nickel and Welding. IARC Press: Lyon, France 1990.
 
32.
Sorahan T.J., Harrington J.M.: Lung cancer in Yorkshire chrome platers, 1972–97. Occup Environ Med 2000; 57: 385–389.
 
33.
Luippold R.S., Mundt K.A., Panko J., et al.: Lung cancer mortality among chromate production workers. Occup Environl Med 2003; 60: 451–457.
 
34.
Costa M.: Toxicity and carcinogenicity of Cr (VI) in animal models and humans. Crit Rev Toxicol 1997; 27(5): 431–442.
 
35.
Wesseling C., Pukkala E., Neuvonen K., et al.: Cancer of the brain and nervous system and occupational exposures in Finnish women. J Occup Environ Med 2002; 44(7): 663–668.
 
36.
Costa M., Klein C.B.: Toxicity and Carcinogenicity of Chromium Compounds in humans Crit Rev Toxicol 2006; 36: 155–163.
 
37.
Cole P., Rodu B. Epidemiologic studies of chrome and cancer mortality: A series of meta-analyses. Regulatory Toxicology and Pharmacology 2005; 43: 225–231.
 
38.
De Flora, S.: Threshold mechanisms and site specificity in chromium (VI) carcinogenesis. Carcinogenesis 2000; 21: 533–541.
 
39.
Crump C., Crump K., Hack E., et al.: Dose–response and risk assessment of airborne hexavalent chromium and lung cancer mortality. Risk Analysis 2003; 23: 1147–1163.
 
40.
Beveridge R., Pintos J., Parent M.E., et al.: Lung Cancer Risk Associated With Occupational Exposure to Nickel, Chromium VI, and Cadmium in Two Population-Based Case–Control Studies in Montreal. Am J Indust Med 2010; 53: 476–485.
 
41.
Davidson T.L., Kluz T., Burns, F.J., et al.: Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice. Toxicol Appl Pharmacol 2004; 196(3): 431–437.
 
42.
The International Programme on Chemical Safety (IPCS). Cadmium. Environmental Health Criteria 134. World Health Organization, Geneva 1992.
 
43.
EEC-European Council Regulation. Commission Regulation (EC) No 66/2001 of 8 March 2001 setting maximum levels for certain contaminants in food stuffs. Off J Eur Commun L 077:0001–0013. 2001.
 
44.
The Centers for Disease Control and Prevention (CDC). Third national report on human exposure to environmental chemicals. Centers for Disease Control and Prevention, Atlanta 2005.
 
45.
International Agency for Research on Cancer (IARC). IARC Monographs on Monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon, 1993: 119–237.
 
46.
Joseph P.: Mechanisms of cadmium carcinogenesis. ToxicolAppl Pharmacol 2009; 238: 272–279.
 
47.
Achanzar W.E., Diwan B.A., Liu J., et al.: Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 2001; 61: 455–458.
 
48.
Vinceti M., Venturelli M., Sighinolfi C., et al.: Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ 2007; 373: 77–81.
 
49.
Pesch B., Haerting J., Ranft U., et al.: Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. Int J Epidemiol 2000; 29: 1014–1024.
 
50.
Hu J., Mao Y., White K.: Renal cell carcinoma and occupational exposure to chemicals in Canada. Occup Med (London) 2002; 52: 157–164.
 
51.
Garcia-Morales P., Saceda M., Kenney N., et al.: Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J BiolChem 1994; 269: 16896–16901.
 
52.
McElroy J.A., Shafer M.M., Trentham-Dietz A., et al.: Cadmium exposure and breast cancer risk.J Natl Cancer Inst 2006; 98:869–872.
 
53.
Martin M.B., Reiter R., Pham T., et al.: Estrogen-like activity of metals in Mcf-7 breast cancer cells. Endocrinology 2003; 144: 2425–2436.
 
54.
Antila E., Mussalo-Rauhamaa H., Kantola M., et al.: Association of cadmium with human breast cancer. Sci Total Environ 1996;186: 251–256.
 
55.
Ionescu J.G,. Novotny J., Stejskal V., et al.: Increased levels of transition metals in breast cancer tissue. Neuroendocrinol Lett 2006; 27(Suppl. 1): 36–39.
 
56.
Strumylaite L., Bogusevicius A., Ryselis S., et al.,: Association between cadmium and breast cancer. Medicina (Kaunas) 2008; 44: 415–420.
 
57.
Strumylaite L., Bogusevicius A., Abdrachmanovas O., et al.: Cadmium concentration in biological media of breast cancer patients Breast Cancer Res Treat DOI 10.1007/s10549-010- 1007-8.
 
58.
Waalkes M.: Cadmium carcinogenesis in review. J Inorg Biochem 2000; 79: 241–244.
 
59.
Pesch B., Haerting J., Ranft U., et al.: Occupational risk factors for renal cell carcinoma:agent specific results from a case-control study in Germany. Int J Epidemiol, 2000; 29: 1014–1024.
 
60.
Epidemiology Research Group. Renal cell carcinoma and occupational exposure in Canada. Occup Med 2002; 52: 157–164.
 
61.
Waalkes M., Misra R.: Cadmium carcinogenicity and genotoxicity (in:) Chang L. (ed.): Toxicology of Metals. CRC Press, Boca Raton, FL, 1996:. 231–244.
 
62.
Schwartz G., Reis I. Is cadmium a cause of human pancreatic cancer? Cancer Epidemiol. Biomarkers Prev 2000; 9: 139–145.
 
63.
Kriegel A.M., Soliman A.S., Zhang Q., et al.: Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt. Environ Health Perspect 2006; 114 (1): 113-119.
 
64.
Sahmoun A.E., Case L.D., Jackson S.A., Schwartz G.G. Cadmium and prostate cancer: A critical epidemiologic analysis cancer investigation 2005; 23:256–263.
 
eISSN:2084-6312
ISSN:1505-7054